
Greystone Associates Analyzes Technology and Therapeutic Factors Influencing Growth of Dry Powder Inhalers
(Amherst, NH) – In recent years, the number of protein-based pharmaceuticals reaching the marketplace has increased exponentially. The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution. It therefore becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs have until recently been marketed almost exclusively for parenteral administration.
Advances in particle technology and the art of particle flow dynamics are enabling an expanding number of drug APIs as potential candidates for inhaled drug delivery via dry powder inhalers. Interest in dry powder inhalation is further benefiting from its ability to create stable dry particle forms of protein and peptide drugs that as liquids are often shipped frozen to preserve their shelf life and require continuous refrigeration.
As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient-friendly and cost-effective. Our analysis demonstrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and commercialization of therapeutic drugs.
More information is available at www.greystoneassociates.org .
About Greystone Associates
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
